Adam R. Levy - 23 Jul 2026 Form 4 Insider Report for NEXGEL, INC. (NXGL)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: NXGL
Reported as of: 23 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jul 2026, 17:25:47 UTC
Prior SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Adam Levy

Key filing fact

Adam R. Levy filed Form 4 for NEXGEL, INC. (NXGL) on 29 Jul 2026.

Key facts

This page summarizes Adam R. Levy's Form 4 filing for NEXGEL, INC. (NXGL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 Jul 2026, 17:25.

Change

Previous filing in this sequence was filed on 23 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001794090 Primary reporting owner

Levy Adam R.

Relationship: Chief Executive Officer, Director
Address: C/O NEXGEL, INC. 2150 CABOT BLVD, WEST,, SUITE B, LANGHORNE
Signature: /s/ Adam Levy
Signature date: 29 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NXGL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +160,000
Change %
Price: $0.000000^*
Shares after: 160,000
Date: 23 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 160,000
Exercise price: $0.6470
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option becomes exercisable as to 40,000 shares on December 31, 2026, and as to the remaining 120,000 shares in 36 equal monthly installments of 3,334 shares (with rounding adjustments) beginning January 31, 2027, in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. In the event of a Change in Control (as defined in the Reporting Person's Executive Employment Agreement with the Issuer, dated July 23, 2026), any unvested portion of the option will accelerate and become immediately exercisable in full.